https://www.avient.com/company/sustainability/sustainability-report/people/community-service-engagement
Avient PAC aligns with candidates who support laws and regulations consistent with sustainable business practices and Avient’s interests, represent a state or district where an Avient facility is located and/ or are active members or leadership of key committees/positions.
In 2023, Avient PAC contributed $6,500 to federal candidates in the U.S. and $6,000 to state candidates in Ohio.
State of Ohio filings and contributions are publicly available at www.ohiosos.gov.
https://www.avient.com/investor-center/news/avient-announces-pricing-650-million-6250-senior-notes-due-2031
the United States
the United States
This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
https://www.avient.com/industries/healthcare/remote-monitoring-wearables
Mobile Devices
IVD Devices
IVD Devices
https://www.avient.com/news/polyone-showcase-polymer-solutions-disinfectant-resistance-mdm-west-2016
Featured medical device polymer, colorant and service solutions include:
Customizable colorants: OnColor™ HC Plus colorants are pre-certified as biocompatible and help medical device manufacturers differentiate their brands using color that resists color-shift and fading while meeting or exceeding regulatory performance requirements for medical devices across a wide range of polymers.
Caption: At MD&M West 2016, PolyOne is showcasing multiple polymer and colorant solutions for medical device housing and component applications.
https://www.avient.com/sites/default/files/2022-04/MEVOPUR LQ for Silicone Elastomers.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your sales
representative for property ranges and min/max specifications.
Processing conditions can cause material properties to shift from the values stated in the information.
Avient products have not been designed for nor are they promoted or intended for use in:
(a) medical devices categorized by either the United States Food and Drug Administration (FDA) or the International Standards Organization (ISO) as an “implant” device; or “Permanent” as defined under
US Pharmacopoeia (USP) or ISO standards; or
(b) active implantable medical devices as defined in EU Directive 90/385/EEC as amended; or
(c) medical devices for “Long Term” use as defined in EU Directive 93/42/EEC as amended.
https://www.avient.com/company/sustainability/sustainability-report/products/product-stewardship-global-chemical-management-product-excellence
We continue to actively monitor the developing regulatory activities at state, national and global levels with respect to per and polyfluoroalkyl substances (PFAS).
PFAS covers thousands of different substances and definitions of PFAS differ across organizations, states, and countries.
International standards cover areas of Quality, Environmental, Health and Safety, Automotive, Medical Device, Responsible Care® and Energy Management.
https://www.avient.com/industries/healthcare/remote-monitoring-wearables/continuous-glucose-monitors-cgm
Mobile Devices
Inhalation Devices
IVD Devices
https://www.avient.com/industries/healthcare/medical-devices-equipment/imaging-technology
Mobile Devices
Inhalation Devices
IVD Devices
https://www.avient.com/sites/default/files/2021-10/remafin-ep-white-masterbatches-for-pharma-application-bulletin_0.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your sales
representative for property ranges and min/max specifications.
Processing conditions can cause material properties to shift from the values stated in the information.
Avient products have not been designed for nor are they promoted or intended for use in:
(a) medical devices categorized by either the United States Food and Drug Administration (FDA) or the International Standards Organization (ISO) as an “implant” device; or “Permanent” as defined under
US Pharmacopoeia (USP) or ISO standards; or
(b) active implantable medical devices as defined in EU Directive 90/385/EEC as amended; or
(c) medical devices for “Long Term” use as defined in EU Directive 93/42/EEC as amended.
https://www.avient.com/news/connected-safer-and-smarter-polyone-collaborates-halo-smart-labs-next-gen-home-safety-devices
Homepage
//
News Center
//
Connected, Safer, and Smarter: PolyOne Collaborates with Halo Smart Labs on Next-Gen Home Safety Devices
CLEVELAND – PolyOne recently worked with Halo Smart Labs in launching Halo and Halo+, devices that go beyond standard smoke alarms by combining home automation with safety technology.
These modern life savers rely on Resilience™ LS, PolyOne’s latest rigid vinyl material formulated for smart home (IoT) devices.